Ametek Stock: Q4 Results Miss Revenue Targets
Ametek's stock experienced a notable 4.2% decline following mixed fourth-quarter 2024 results that partially missed analyst expectations. While the technology company exceeded projections with an adjusted earnings per share of $1.87, revenue fell short at $1.76 billion compared to the anticipated $1.82 billion. The outlook for the first quarter of 2025 further dampened market sentiment, with projected adjusted earnings per share of $1.67 to $1.69 falling significantly below analyst estimates of $1.75.
Segment Performance and Future Outlook
The company's performance showed divergent trends across its divisions, with the Electronic Instruments Group reporting a 2% revenue decline to $1.21 billion. In contrast, the Electromechanical Group achieved 11% growth, reaching $546.7 million, bolstered by the Paragon Medical acquisition. Despite mixed results, operational efficiency improved as evidenced by a 90 basis point increase in operating margin to 26.6%. Management projects low single-digit revenue growth for the full year 2025, indicating cautious optimism amid current market conditions.
Ad
Ametek Stock: New Analysis - 05 FebruaryFresh Ametek information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Read our updated Ametek analysis...Source StockWorld
Ametek Inc. Aktie
Einige positive Einschätzungen für Ametek Inc. mit mehr Buy- als Sell-Einschätzungen.
Ein prognostiziertes Kursziel von 197 € für Ametek Inc. zeigt ein Potenzial von über 20% im Vergleich zum aktuellen Kurs von 159.6 €.